NYSE:PFE Pfizer (PFE) Stock Price, News & Analysis $30.04 -0.39 (-1.27%) Closing price 10/23/2026 03:59 PM EasternExtended Trading$30.02 -0.01 (-0.04%) As of 10/23/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Pfizer Stock (NYSE:PFE) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Pfizer alerts:Sign Up Key Stats Today's Range$29.81▼$30.3250-Day Range$26.88▼$30.4052-Week Range$23.62▼$30.44Volume29.45 million shsAverage Volume29.68 million shsMarket Capitalization$171.19 billionP/E Ratio9.97Dividend Yield5.73%Price Target$28.72Consensus RatingHold Company Overview Pfizer Inc. is a global biopharmaceutical company that discovers, develops, manufactures and commercializes prescription medicines and vaccines. Its research activities span areas including oncology, internal medicine, inflammation and immunology, hospital care, infectious diseases and rare diseases. The company’s portfolio includes medicines such as Eliquis, Ibrance, Prevnar and Vyndaqel, as well as vaccines including Comirnaty, Abrysvo and Prevnar. Pfizer also develops treatments through internal research, licensing agreements and collaborations with other pharmaceutical and biotechnology companies. Founded in Brooklyn, New York, in 1849 by Charles Pfizer and Charles Erhart, Pfizer has grown into an international healthcare company serving patients and healthcare providers in markets around the world. The company is headquartered in New York City and is led by Chairman and Chief Executive Officer Albert Bourla.AI Generated. May Contain Errors. Read More Pfizer Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks63rd Percentile Overall ScorePFE MarketRank™: 3.15719063545 of 5 starsPfizer scored higher than 63% of companies evaluated by MarketBeat, and ranked 315th out of 907 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingHold Consensus RatingPfizer has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on no strong buy ratings, 5 buy ratings, 14 hold ratings, and 2 sell ratings.Upside/DownsideThe consensus price target for Pfizer is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoveragePfizer has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Pfizer's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Earnings GrowthEarnings for Pfizer are expected to remain at $2.95 per share in the coming year.Price to Earnings Ratio vs. the MarketThe P/E ratio of Pfizer is 9.97, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 35.62.Price to Earnings Ratio vs. SectorThe P/E ratio of Pfizer is 9.97, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 207.10.Price to Earnings Growth RatioPfizer has a PEG Ratio of 2.07. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPfizer has a P/B Ratio of 1.97. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Pfizer's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.65% of the float of Pfizer has been sold short.Short Interest Ratio / Days to CoverPfizer has a short interest ratio ("days to cover") of 4.41.Change versus previous monthShort interest in Pfizer has recently decreased by 3.21%, indicating that investor sentiment is improving. Dividend4.2 / 5Dividend StrengthStrong Dividend LeadershipPfizer is a leading dividend payer. It pays a dividend yield of 5.65%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthPfizer has been increasing its dividend for 16 years.Dividend CoverageThe dividend payout ratio of Pfizer is 226.32%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on earnings estimates, Pfizer will have a dividend payout ratio of 58.31% next year. This indicates that Pfizer will be able to sustain or increase its dividend.Read more about Pfizer's dividend. News and Social Media3.4 / 5News Sentiment0.37 News SentimentPfizer has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 43 news articles for Pfizer this week, compared to 9 articles on an average week.Search Interest122 people have searched for PFE on MarketBeat in the last 30 days. This is an increase of 30% compared to the previous 30 days.MarketBeat Follows73 people have added Pfizer to their MarketBeat watchlist in the last 30 days. This is an increase of 329% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Pfizer insiders have not sold or bought any company stock.Percentage Held by Insiders0.62% of the stock of Pfizer is held by insiders.Percentage Held by Institutions68.36% of the stock of Pfizer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Pfizer's insider trading history. Receive PFE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pfizer and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PFE Stock News HeadlinesPfizer's Dividend Yield Is One of the Highest in the S&P 500. Here's Why the Dividend Is Safer Than It Might Seem2 hours ago | fool.comPfizer's Dividend Yield Is One of the Highest in the S&P 500. Here's Why the Dividend Is Safer Than It Might Seem2 hours ago | fool.comYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strategy guide, titled How To Turn 100 Into 1000 Gains, before it moves behind a paywall. The guide walks through options trading concepts the team uses in its own research and education materials. Once the paywall goes up, free access ends for good. | TradeWins (Ad)Is Pfizer (PFE) Cheap As Its Enodia Deal Fuels Oncology Growth Hopes?October 23 at 8:38 PM | finance.yahoo.com3 Stocks With Yields Big Enough to Make Election Volatility Easier to Stomach (PFE)Lincoln National, AbbVie and Phillips 66 offer dividends that pay investors through midterm volatility, backed by rising rates, steady drug demand and oil risk.October 23 at 7:25 AM | marketbeat.comTech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs (PFE)Biotech and pharma stocks, tracked by the iShares Biotechnology ETF, have shown relative strength amid the tech sell-off, with Eli Lilly and Pfizer standing out as top performers.October 20, 2026 | marketbeat.com3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury NoteWith the 10-year Treasury yielding around 5.3%, Pfizer, Energy Transfer, and Plains All American offer stocks under $30 with dividend yields between 6% and 7%.October 3, 2026 | marketbeat.comTreasury Yields Hit a 19-Year High—These 2 Bond ETFs Offer Monthly Income (PFE)As bond yields climb amid record U.S. debt, Vanguard's BSV and VCIT ETFs offer TTM yields of about 4% and 5%, respectively, with potential for rising monthly distributions.September 24, 2026 | marketbeat.comSee More Headlines PFE Stock Analysis - Frequently Asked Questions How have PFE shares performed this year? Pfizer's stock was trading at $24.90 at the beginning of the year. Since then, PFE stock has increased by 20.6% and is now trading at $30.0350. How were Pfizer's earnings last quarter? Pfizer Inc. (NYSE:PFE) posted its quarterly earnings data on Tuesday, August, 4th. The biopharmaceutical company reported $0.77 EPS for the quarter, beating the consensus estimate of $0.68 by $0.09. Pfizer's revenue for the quarter was up 2.6% compared to the same quarter last year. Read the conference call transcript. Does Pfizer have any subsidiaries? The following companies are subsidiaries of Pfizer: ReViral, Arena, Trillium Therapeutics, Amplyx Pharmaceuticals, Array BioPharma, Therachon, Medivation, and others. Who are Pfizer's major shareholders? Top institutional investors of Pfizer include Artemis Investment Management LLP (0.07%), Mn Services Vermogensbeheer B.V. (0.03%), Valley Wealth Managers Inc. (0.02%) and Sound Income Strategies LLC (0.01%). Insiders that own company stock include Ronald E Blaylock and Scott Gottlieb. View institutional ownership trends. How do I buy shares of Pfizer? Shares of PFE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Pfizer own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pfizer investors own include NVIDIA (NVDA), AT&T (T), Johnson & Johnson (JNJ), Verizon Communications (VZ), Intel (INTC), Tesla (TSLA) and AbbVie (ABBV). Company Calendar Record date for 9/1 Dividend7/24/2026Ex-Dividend for 9/1 Dividend7/24/2026Last Earnings8/04/2026Dividend Payable9/01/2026Today10/23/2026Next Earnings (Estimated)11/03/2026Record date for 12/7 Dividend11/06/2026Ex-Dividend for 12/7 Dividend11/06/2026Dividend Payable12/07/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 PFE's financial health is in the Green zone, according to TradeSmith. PFE has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNYSE:PFE CIK78003 Webwww.pfizer.com Phone(212) 733-2323Fax302-655-5049Employees75,000Year Founded1849Price Target and Rating Average Price Target for Pfizer$28.72 High Price Target$35.00 Low Price Target$25.00 Potential Upside/Downside-4.4%Consensus RatingHold Rating Score (0-4)2.14 Research Coverage21 Analysts Profitability EPS (Trailing Twelve Months)$0.76 Trailing P/E Ratio9.97 Forward P/E Ratio10.18 P/E Growth2.07Net Income$7.77 billion Net Margins6.80% Pretax Margin6.61% Return on Equity19.63% Return on Assets8.46% Debt Debt-to-Equity Ratio0.71 Current Ratio1.27 Quick Ratio0.96 Sales & Book Value Annual Sales$62.58 billion Price / Sales2.74 Cash Flow$4.34 per share Price / Cash Flow6.92 Book Value$15.26 per share Price / Book1.97Miscellaneous Outstanding Shares5,699,670,000Free Float5,664,336,000Market Cap$171.19 billion OptionableOptionable Beta0.32 Social Links 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (NYSE:PFE) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | Sponsored$29.97 or $0 todayThe 0DTE Game Plan normally sells for 29.97, but it is free today through this link. Inside is a straightfo...Profits Run | SponsoredWATCH THIS BEFORE DECEMBER 8th!!James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pfizer Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pfizer With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
